HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

7,8-Dihydroxy-4-methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signaling.

Abstract
Coumarins have attracted intense interest in recent years because they have been identified from natural sources, especially green plants and have diverse pharmacological properties. In this study, we investigated whether 7,8-dihydroxy-4-methylcoumarin (DHMC) caused apoptosis in A549 human non-small cell lung carcinoma cells (NSCLC) and, if so, by what mechanisms. Here, we show that, in A549 human NSCLC cells, DHMC induces apoptosis through mitochondria-mediated caspase-dependent pathway. Although an increase in the levels of reactive oxygen species (ROS) was observed, pre-treatment with antioxidant showed no protective effect against DHMC-induced apoptosis. In addition, our immunoblot data revealed that DHMC treatment led to down-regulation of Bcl-xl, Bax, p21, Cox-2, p53 and upregulation of c-Myc. Results in the present study for the first time suggest that DHMC induces apoptosis in human lung A549 cells through partial inhibition of ERK/MAPK signaling.
AuthorsAnita Goel, Ashok K Prasad, Virinder S Parmar, Balaram Ghosh, Neeru Saini
JournalFEBS letters (FEBS Lett) Vol. 581 Issue 13 Pg. 2447-54 (May 29 2007) ISSN: 0014-5793 [Print] England
PMID17485089 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 7,8-dihydroxy-4-methylcoumarin
  • Coumarins
  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • MAP Kinase Kinase 2
Topics
  • Adenocarcinoma
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Coumarins (pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Lung Neoplasms
  • MAP Kinase Kinase 2 (drug effects)
  • Mitochondria (drug effects, physiology)
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: